<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a 77-year-old man with <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, x-rays demonstrated an irregular stenotic process in the lower third of the esophagus, suggesting <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Endoscopy disclosed moderate narrowing of the lumen and several <z:mpath ids='MPATH_579'>ulcers</z:mpath> separated by bulges </plain></SENT>
<SENT sid="2" pm="."><plain>Serial biopsies revealed Barrett's mucosa </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="1" ids="3699">Cimetidine</z:chebi> 1 g/day led to prompt improvement and endoscopically there was a disappearance of the lesions after 3 months of therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Reduction of the drug to 400 mg/day 3 months later with supplements of antacids and metoclopramide was followed by reappearance of symptoms and recurrence of a deep <z:mpath ids='MPATH_579'>ulcer</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Raising the dose of <z:chebi fb="1" ids="3699">cimetidine</z:chebi> to 1 g/day again resulted in healing and since then a maintenance dose of 600 mg <z:chebi fb="1" ids="3699">cimetidine</z:chebi> with antacids and metoclopramide has been successful in preventing recurrence </plain></SENT>
<SENT sid="6" pm="."><plain>This long-term study in a patient with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> showed 1) that <z:chebi fb="1" ids="3699">cimetidine</z:chebi> can be effective in treating such patients; 2) the prophylactic value of multitherapy as a maintenance regimen, and 3) the importance of careful follow-up </plain></SENT>
</text></document>